Publication Information

{'id': 'https://openalex.org/W3023935924', 'doi': 'https://doi.org/10.1097/ju.0000000000000969.011', 'title': 'PD59-11 TARGETING BCL2 TO INCREASE ENZALUTAMIDE SENSITIVITY TO BETTER SUPPRESS PROSTATE CANCER PROGRESSION THROUGH ALTERING ARV7 PROTEIN DEGRADATION', 'display_name': 'PD59-11 TARGETING BCL2 TO INCREASE ENZALUTAMIDE SENSITIVITY TO BETTER SUPPRESS PROSTATE CANCER PROGRESSION THROUGH ALTERING ARV7 PROTEIN DEGRADATION', 'publication_year': 2020, 'publication_date': '2020-04-01', 'ids': {'openalex': 'https://openalex.org/W3023935924', 'doi': 'https://doi.org/10.1097/ju.0000000000000969.011', 'mag': '3023935924'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1097/ju.0000000000000969.011', 'pdf_url': 'https://www.auajournals.org/doi/pdf/10.1097/JU.0000000000000969.011', 'source': {'id': 'https://openalex.org/S30525748', 'display_name': 'The Journal of Urology', 'issn_l': '0022-5347', 'issn': ['0022-5347', '1527-3792'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://www.auajournals.org/doi/pdf/10.1097/JU.0000000000000969.011', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5102357374', 'display_name': 'Hua Xu', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Hua Xu*', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5102357374'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 61}, 'biblio': {'volume': '203', 'issue': 'Supplement 4', 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9991, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9991, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12465', 'display_name': 'Cancer, Lipids, and Metabolism', 'score': 0.994, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11618', 'display_name': 'Cholesterol and Lipid Metabolism', 'score': 0.9075, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/enzalutamide', 'display_name': 'Enzalutamide', 'score': 0.9886215}], 'concepts': [{'id': 'https://openalex.org/C2776551883', 'wikidata': 'https://www.wikidata.org/wiki/Q1996756', 'display_name': 'Enzalutamide', 'level': 5, 'score': 0.9886215}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.9272831}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8189493}, {'id': 'https://openalex.org/C61367390', 'wikidata': 'https://www.wikidata.org/wiki/Q416601', 'display_name': 'Androgen receptor', 'level': 4, 'score': 0.64316887}, {'id': 'https://openalex.org/C2777899217', 'wikidata': 'https://www.wikidata.org/wiki/Q4759439', 'display_name': 'Androgen deprivation therapy', 'level': 4, 'score': 0.6102051}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.567218}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.54284906}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.46250886}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.45759827}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1097/ju.0000000000000969.011', 'pdf_url': 'https://www.auajournals.org/doi/pdf/10.1097/JU.0000000000000969.011', 'source': {'id': 'https://openalex.org/S30525748', 'display_name': 'The Journal of Urology', 'issn_l': '0022-5347', 'issn': ['0022-5347', '1527-3792'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1097/ju.0000000000000969.011', 'pdf_url': 'https://www.auajournals.org/doi/pdf/10.1097/JU.0000000000000969.011', 'source': {'id': 'https://openalex.org/S30525748', 'display_name': 'The Journal of Urology', 'issn_l': '0022-5347', 'issn': ['0022-5347', '1527-3792'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3122236002', 'https://openalex.org/W3024577600', 'https://openalex.org/W3023935924', 'https://openalex.org/W2931472946', 'https://openalex.org/W2773216890', 'https://openalex.org/W2681186693', 'https://openalex.org/W2593283143', 'https://openalex.org/W2479406918', 'https://openalex.org/W2180958531', 'https://openalex.org/W1993338898'], 'abstract_inverted_index': {'You': [0], 'have': [1], 'accessJournal': [2], 'of': [3, 95, 112, 127, 161, 270, 307, 326, 361, 373, 390, 467, 486, 531, 539, 546, 549, 579, 585], 'UrologyProstate': [4], 'Cancer:': [5], 'Basic': [6], 'Research': [7], '&': [8, 609], 'Pathophysiology': [9], 'III': [10], '(PD59)1': [11], 'Apr': [12], '2020PD59-11': [13], 'TARGETING': [14], 'BCL2': [15, 148, 156, 178, 243, 253, 259, 295, 327, 396, 511], 'TO': [16, 20], 'INCREASE': [17], 'ENZALUTAMIDE': [18], 'SENSITIVITY': [19], 'BETTER': [21], 'SUPPRESS': [22], 'PROSTATE': [23], 'CANCER': [24], 'PROGRESSION': [25], 'THROUGH': [26], 'ALTERING': [27], 'ARV7': [28], 'PROTEIN': [29], 'DEGRADATION': [30], 'Hua': [31, 33, 621], 'Xu*': [32, 35, 622], 'Xu*Hua': [34], 'More': [36, 623], 'articles': [37, 624], 'by': [38, 191, 329, 593, 612, 625], 'this': [39, 626], 'author': [40, 627], 'View': [41], 'All': [42, 629], 'Author': [43], 'Informationhttps://doi.org/10.1097/JU.0000000000000969.011AboutPDF': [44], 'ToolsAdd': [45], 'to': [46, 71, 152, 174, 213, 311, 314, 369, 423, 430, 463, 483, 561, 568, 576], 'favoritesDownload': [47], 'CitationsTrack': [48], 'CitationsPermissionsReprints': [49], 'ShareFacebookLinked': [50], 'InTwitterEmail': [51], 'Abstract': [52], 'INTRODUCTION': [53], 'AND': [54], 'OBJECTIVE:': [55], 'Androgen': [56], 'deprivation': [57], 'therapy': [58], '(ADT)': [59], 'with': [60, 179, 201, 364, 512, 542, 566], 'antiandrogens': [61], 'targeting': [62, 155, 252, 508], 'androgens/androgen': [63], 'receptor': [64, 272, 469], '(AR)': [65, 273, 470], 'signaling': [66], 'is': [67, 296, 397], 'the': [68, 110, 166, 268, 304, 316, 371, 381, 388, 404, 409, 420, 425, 465, 484, 499, 559], 'standard': [69, 111], 'used': [70, 212], 'treat': [72, 569], 'prostate': [73, 84, 100, 117, 133, 143, 162, 188, 236, 291, 500, 526, 570], 'cancer': [74, 85, 90, 101, 118, 134, 144, 163, 189, 237, 292, 501, 527, 571], 'in': [75, 129, 186, 205, 247, 284, 337, 340, 443, 519, 564], 'different': [76], 'clinical': [77], 'settings': [78], 'besides': [79], 'surgical': [80], 'treatment.': [81], 'However,': [82, 120, 356], 'most': [83], 'patients': [86, 231, 239], 'will': [87, 497], 'eventually': [88], 'develop': [89], 'progression': [91], 'despite': [92, 125], 'castrate': [93], 'levels': [94, 198, 457, 536], 'testosterone,': [96], 'into': [97], 'castration': [98, 115, 131], 'resistant': [99, 116, 132, 142, 290, 525, 575], '(CRPC).': [102], 'The': [103, 170, 321], 'recently': [104], 'developed': [105], 'antiandrogen,': [106], 'Enzalutamide,': [107], 'has': [108], 'reformed': [109], 'care': [113], 'for': [114, 387], 'patients.': [119], 'Enzalutamide': [121, 128, 141, 159, 176, 184, 264, 286, 289, 433, 509, 517, 521, 524, 567], 'resistance': [122], 'inevitably': [123], 'emerges': [124], 'success': [126], 'prolonging': [130], 'patients’': [135], 'survival.': [136], 'Here': [137], 'we': [138, 301, 411], 'found': [139], 'that': [140, 242, 251, 324, 350, 380, 401, 495, 507], 'cells': [145, 190, 528], 'had': [146], 'higher': [147], 'expression.': [149, 320, 394, 554], 'We': [150, 222], 'aimed': [151], 'test': [153, 183], 'whether': [154], 'would': [157], 'influence': [158, 432], 'sensitivity': [160, 185, 265, 518], 'and': [164, 182, 204, 232, 240, 266, 274, 280, 288, 318, 332, 343, 345, 375, 392, 427, 446, 448, 471, 477, 523, 537, 551, 589, 598, 617], 'identify': [165], 'potential': [167, 257, 305], 'mechanism.': [168], 'METHODS:': [169], 'study': [171, 505, 557], 'was': [172, 211, 244, 384], 'designed': [173], 'target': [175], 'induced': [177, 510], 'inhibitor': [180, 513], 'ABT263': [181, 261, 330, 351, 415, 435, 496, 514, 563], 'Enz-resistant': [187], 'MTT': [192], 'assay.': [193], 'Cellular': [194], 'reactive': [195, 454, 533], 'oxygen': [196, 455, 534], 'species': [197, 456, 535], 'were': [199], 'detected': [200], 'dihydroethidium': [202], 'staining,': [203], 'vitro': [206], 'deubiquitinating': [207], 'enzyme': [208], 'activity': [209, 310, 328, 363, 462, 541], 'assay': [210], 'evaluate': [214], 'ubiquitin': [215], 'specific': [216], 'protease': [217], '26': [218], '(USP26)': [219], 'activity.': [220], 'RESULTS:': [221], 'retrospectively': [223], 'performed': [224], 'an': [225], 'RNA': [226], 'sequencing': [227], 'among': [228], '625': [229, 233], 'CRPC': [230], 'matched': [234], 'hormone-sensitive': [235], '(HSPC)': [238], 'revealed': [241, 323], 'significant': [245], 'increased': [246], 'CRPC,': [248], 'which': [249, 481], 'indicated': [250], 'might': [254, 458], 'be': [255], 'a': [256, 297, 398, 543], 'option.': [258], 'inhibitor,': [260], 'could': [262, 352, 416, 437, 515], 'increase': [263, 267, 464, 485, 516, 545], 'ubiquitination': [269, 466], 'androgen': [271, 468], 'AR': [275, 317, 374, 391, 426, 472, 550], 'splice': [276, 473], 'variant': [277, 474], '7': [278, 475], '(ARv7)': [279, 476], 'their': [281, 478], 'ubiquitin/proteasome-dependent': [282, 479, 547], 'degradation': [283, 548], 'both': [285, 341, 444, 520], 'sensitive': [287, 522], 'cells.': [293, 451], 'As': [294, 395], 'classical': [298], 'anti-apoptosis': [299], 'protein,': [300], 'then': [302, 412, 459], 'tested': [303, 413], 'linkage': [306], 'its': [308, 312], 'anti-apoptotic': [309], 'ability': [313], 'alter': [315, 403], 'ARv7': [319, 376, 393, 428, 552], 'results': [322], 'inhibition': [325, 360], '(with': [331], 'without': [333], 'Enz': [334, 487], 'treatment)': [335], 'resulted': [336], 'cleaved-PARP': [338], 'expression': [339, 429], 'EnzS1-C4-2': [342, 445], 'EnzR1-C4-2': [344, 447], 'EnzR3-CWR22Rv1': [346, 449], 'PCa': [347, 354, 450], 'cells,': [348], 'suggesting': [349, 379], 'promote': [353], 'apoptosis.': [355], 'blocking': [357], 'apoptosis': [358], 'through': [359, 529], 'caspase': [362], 'Z-VAD-FMK': [365], '(pan-caspase': [366], 'inhibitor)': [367], 'failed': [368], 'reverse': [370], 'decrease': [372, 389, 424], 'protein': [377, 400, 553], 'expression,': [378], 'apoptotic': [382], 'pathway': [383], 'unlikely': [385], 'responsible': [386], 'mitochondria': [399, 405], 'may': [402], 'function': [406, 417], 'via': [407, 418], 'modulating': [408], 'ROS,': [410], 'weather': [414], 'altering': [419], 'cellular': [421, 440, 453, 532], 'ROS': [422, 441], 'further': [431], 'sensitivity.': [434, 488], 'treatment': [436], 'significantly': [438], 'induce': [439], 'level': [442], 'Elevated': [452], 'inhibit': [460], 'USP26': [461, 540], 'degradation,': [480], 'contributed': [482], 'In': [489], 'vivo': [490], 'mouse': [491], 'model': [492], 'also': [493], 'demonstrates': [494], 'suppress': [498], 'progression.': [502], 'CONCLUSIONS:': [503], 'This': [504, 555], 'demonstrated': [506], 'induction': [530], 'suppression': [538], 'consequent': [544], 'preclinical': [556], 'established': [558], 'foundation': [560], 'use': [562], 'combination': [565], 'patients,': [572], 'especially': [573], 'those': [574], 'Enzalutamide.': [577], 'Source': [578], 'Funding:': [580], 'National': [581], 'Natural': [582], 'Science': [583], 'Foundation': [584], 'China': [586], '(No.': [587], '81472377': [588], '81802570)': [590], '©': [591], '2020': [592, 611], 'American': [594, 613], 'Urological': [595, 614], 'Association': [596, 615], 'Education': [597, 616], 'Research,': [599, 618], 'Inc.FiguresReferencesRelatedDetails': [600], 'Volume': [601], '203Issue': [602], 'Supplement': [603], '4April': [604], '2020Page:': [605], 'e1209-e1209': [606], 'Advertisement': [607, 630], 'Copyright': [608], 'Permissions©': [610], 'Inc.MetricsAuthor': [619], 'Information': [620], 'Expand': [628], 'PDF': [631], 'downloadLoading': [632], '...': [633]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3023935924', 'counts_by_year': [], 'updated_date': '2024-12-11T04:10:54.062274', 'created_date': '2020-05-13'}